| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 05/23/2002 | WO2002039977A2 A method for restoring a foot fat-pad |
| 05/23/2002 | WO2002039975A1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling |
| 05/23/2002 | WO2002039955A2 Biodegradable mixed polymeric micelles for drug delivery |
| 05/23/2002 | WO2002039952A2 Synergistic ecta compositions |
| 05/23/2002 | WO2002039834A1 Nutritional composition for an immune condition |
| 05/23/2002 | WO2002039832A1 Use of lactitol for improving intestinal microflora |
| 05/23/2002 | WO2002034267A8 Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states |
| 05/23/2002 | WO2002015903A3 Novel pharmaceutical composition for administering n-0923 |
| 05/23/2002 | WO2002003969A3 Transdermal therapeutic system for highly dispersed silicon dioxide |
| 05/23/2002 | WO2001098235A3 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants |
| 05/23/2002 | WO2001097749A3 The use of synthetic, non-hormonal 21-aminosteroids and thereof |
| 05/23/2002 | WO2001093804A3 Hepatitis c virus conjugates |
| 05/23/2002 | WO2001091720A3 Preparation of injectable suspensions having improved injectability |
| 05/23/2002 | WO2001089494A3 Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases |
| 05/23/2002 | WO2001087346A3 Dendritic cells loaded with toxic substances |
| 05/23/2002 | WO2001085116A3 Synergistic antiplaque/antigingivitis oral composition |
| 05/23/2002 | WO2001083774A3 Novel mutated form of arginine deiminase |
| 05/23/2002 | WO2001082971A3 Cyclodextrin containing glycopeptide antibiotic compositions |
| 05/23/2002 | WO2001082895A3 Guaifenesin sustained release formulation and tablets |
| 05/23/2002 | WO2001080828A3 Improved water-insoluble drug particle process |
| 05/23/2002 | WO2001079444A3 Albumin fusion proteins |
| 05/23/2002 | WO2001078692A3 Membrane delivery system |
| 05/23/2002 | WO2001078660A3 Topical micronutrient delivery system and uses thereof |
| 05/23/2002 | WO2001077687A3 Prion-binding peptidic ligands and methods of using same |
| 05/23/2002 | WO2001076637A3 Peptide conjugates for drug delivery |
| 05/23/2002 | WO2001049273A3 Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation |
| 05/23/2002 | WO2001035941A3 Novel composition based on a thiazolidinedione and metformin and use |
| 05/23/2002 | WO2000071121A9 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 05/23/2002 | US20020062125 Method of drug delivery to interstitial regions of the myocardium |
| 05/23/2002 | US20020062102 Electrodes and method for manufacturing electrodes for electrically assisted drug delivery |
| 05/23/2002 | US20020061932 Pharmaceutical composition |
| 05/23/2002 | US20020061907 Macrolide compound, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener; topical for skin disorders |
| 05/23/2002 | US20020061906 Aerosol compositions |
| 05/23/2002 | US20020061884 And from 50 to 99% by weight of a vegetable oil selected from olive oil, peanut oil, soybean oil, corn oil, safflower oil, sunflower oil, canola oil, or walnut oil |
| 05/23/2002 | US20020061873 Having high bioavailability levels and reduced variability of bioavailability by use of dispersed, colloidal structures, colloids or analogous structures of the drug, a hydrophilic component, and a surfactant |
| 05/23/2002 | US20020061852 Methods of therapy with thrombin derived peptides |
| 05/23/2002 | US20020061843 Use of mCRP for delivery of materials into cells |
| 05/23/2002 | US20020061838 Peptide pharmaceutical formulations |
| 05/23/2002 | US20020061835 In vivo delivery methods and compositions |
| 05/23/2002 | US20020061592 Liquid or frozen mixture for use in maintaince of viral particles; for use in gene therapy |
| 05/23/2002 | US20020061547 Microorganism for use in the generation of colored particle; for use in foods, cosmetics and medicine |
| 05/23/2002 | US20020061340 Self-preserved antibacterial nasal, inhalable, and topical ophthalmic preparations and medications |
| 05/23/2002 | US20020061336 Also comprising a hydrogel, for use in the treatment of a subject by particle injection |
| 05/23/2002 | US20020061335 Powdered/microfibrillated cellulose |
| 05/23/2002 | US20020061314 Administering to animal live vaccine containing organisms to develop immunological response, maintaining animal free from drugs effective against infectious organism for period of one life or infectious cycle of organism, administering drug |
| 05/23/2002 | US20020061311 For prevention or treatment of autoimmune diseases/influenza and clinical allergic hypersensitivities, and for prevention of allograft rejection |
| 05/23/2002 | US20020061308 Bcl-2 gene proteins conjugated to a ligand for a cell surface antigen of a specific cell type |
| 05/23/2002 | US20020061307 Polyalkylene oxide-modified single chain polypeptides |
| 05/23/2002 | US20020061294 Mononuclear phagocytes in therapeutic drug delivery |
| 05/23/2002 | US20020061287 Process of making a compound by forming a polymer from a template drug |
| 05/23/2002 | US20020061281 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 05/23/2002 | US20020061280 For identification of the sentinel lymph node that drains the tissue or organ of interest, such as those affected by neoplasm or disease; contrast agent of specified particle size associates with said lymph structure |
| 05/23/2002 | US20020059939 Device and method for the cessation of smoking |
| 05/23/2002 | DE10058119A1 Pharmaceutical kit containing repinotan, for use in acute treatment of neurological disorders such as stroke, including assay composition for determining body repinotan levels to optimize dosage |
| 05/23/2002 | DE10057754A1 New cyclic sulfonamido-substituted pyrazolo (3,4-b) pyridine derivatives, are soluble guanylate cyclase stimulants useful e.g. for treating cardiovascular or central nervous system diseases, sexual dysfunction or inflammation |
| 05/23/2002 | DE10056104A1 Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts |
| 05/23/2002 | DE10055469A1 Konjugat, dessen Herstellung und Verwendung Conjugate, its preparation and use |
| 05/23/2002 | CA2650698A1 Copolyvidone-containing preparation |
| 05/23/2002 | CA2429460A1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | CA2429103A1 Process for producing microparticles |
| 05/23/2002 | CA2429100A1 Parenterally administrable microparticles |
| 05/23/2002 | CA2428997A1 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | CA2428837A1 Microspheres of pancreatic enzymes with high stability |
| 05/23/2002 | CA2428802A1 Camptothecin compounds with a sulfhydryl group |
| 05/23/2002 | CA2428782A1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and its method of preparation |
| 05/23/2002 | CA2428707A1 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 05/23/2002 | CA2428189A1 Pharmaceutival preparations comprising corticosteroids and antiinfective agents |
| 05/23/2002 | CA2427896A1 Carrier vectors through an epithelium with tight junctions |
| 05/22/2002 | EP1207391A1 Method for screening targeting dds preparation |
| 05/22/2002 | EP1207164A2 Method for producing a powder containing crystalline maltitol particles |
| 05/22/2002 | EP1206933A1 Compositions comprising caprylyl glycol and preservatives |
| 05/22/2002 | EP1206928A1 Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
| 05/22/2002 | EP1206485A2 New effectors of dipeptidyl peptidase iv for topical use |
| 05/22/2002 | EP1206466A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 05/22/2002 | EP1206429A2 Stilbenes with vascular damaging activity |
| 05/22/2002 | EP1206290A1 Cyclodextrin containing pressure sensitive adhesives |
| 05/22/2002 | EP1206285A2 Drug-carrier complexes and methods of use thereof |
| 05/22/2002 | EP1206284A1 Method for delivery of therapeutic agents using a solution of dextrin |
| 05/22/2002 | EP1206283A2 Improved cellular uptake of bioactive agents |
| 05/22/2002 | EP1206282A1 Film forming polymers, methods of use, and devices and applications thereof |
| 05/22/2002 | EP1206281A1 Moxifloxacin formulation containing common salt |
| 05/22/2002 | EP1206280A1 Edible holographic products, particularly pharmaceuticals and methods and apparatus for producing same |
| 05/22/2002 | EP1206272A1 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/22/2002 | EP1206268A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 05/22/2002 | EP1206266A2 Formulations for parenteral use of estramustine phosphate and albumin |
| 05/22/2002 | EP1206259A2 Use of substance p antagonists for the treatment of adenocarcinoma |
| 05/22/2002 | EP1206258A1 Compositions containig esthers for treating parasitic infestations of organisms |
| 05/22/2002 | EP1206255A1 COMPOUNDS OBTAINED FROM i SALVIA SPECIES /i HAVING ANTIVIRAL ACTIVITY |
| 05/22/2002 | EP1206254A1 Drug releasing biodegradable fiber implant |
| 05/22/2002 | EP1206253A1 Pharmaceutical preparation containing nanosol |
| 05/22/2002 | EP1206252A1 Amplification of folate-mediated targeting to tumor cells using polymers |
| 05/22/2002 | EP1206251A1 Amplification of folate-mediated targeting to tumor cells using nanoparticles |
| 05/22/2002 | EP1206249A1 Hydrodynamically balancing oral drug delivery system |
| 05/22/2002 | EP1206248A2 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 05/22/2002 | EP1206246A1 Means for creating a mass having structural integrity |
| 05/22/2002 | EP1206245A2 Phospholipid gel |
| 05/22/2002 | EP1206244A2 Aqueous pharmaceutical composition containing moxifloxacin or salts thereof |
| 05/22/2002 | EP1206189A1 Rotavirus vaccine formulations |
| 05/22/2002 | EP1152776B1 Biodegradable, injectable oligomer-polymer composition |
| 05/22/2002 | EP1109558B1 Sustained release ranolazine formulations |